Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation

from Latest Results for Applied Health Economics and Health Policy at http://bit.ly/1Lrg4Wi on February 29, 2016 Abstract Background Atrial fibrillation (AF) poses a significant economic burden. An increasing number of interventions for AF require cost-effectiveness analysis with decision–analytic modeling to demonstrate value. However, high-quality cost estimates of AF that can be used to inform decision–analytic […]

Effectiveness and Cost of a Personalized Reminder Intervention to Improve Adherence to Glaucoma Care

from Latest Results for Applied Health Economics and Health Policy at http://bit.ly/21EoIES on February 29, 2016 Abstract Background Glaucoma is the leadi ng cause of irreversible blindness in the USA. Glaucomatous vision loss is preventable with proper eye care, including appointment adherence. Therefore, interventions that improve appointment adherence can reduce the number of patients with […]